Non-Invasive Monitoring Systems, Inc. (NIMS), a company previously engaged in the development and marketing of non-invasive therapeutic platforms, has released its Form 10-K report. The report provides a comprehensive overview of the company's financial performance, business operations, strategic initiatives, and the challenges it faces as it navigates its current status as a shell company.
Financial Highlights
- Operating loss: $160,000, reflecting an increase from the previous year's $59,000 due to a $118,000 accounts payable adjustment offset by a $17,000 decrease in professional fees.
- Net loss: $222,000, compared to $113,000 in the prior year, primarily due to the accounts payable adjustment recognized as a reduction in operating expenses in the previous fiscal year.
- Basic and diluted loss per common share: $(0.00), consistent with the previous year, indicating no change in per-share loss despite the increased net loss.
Business Highlights
- Company Overview: Non-Invasive Monitoring Systems, Inc. (NIMS) was primarily engaged in the development, manufacture, and marketing of non-invasive, whole body periodic acceleration (WBPA) therapeutic platforms. These platforms were designed to aid in increasing local circulation, relieving minor aches and pains, and reducing morning stiffness. However, the company discontinued operations in May 2019 and is currently classified as a shell company.
- Discontinued Operations: The company ceased its operations related to WBPA therapeutic platforms in May 2019. As a result, certain assets, liabilities, and expenses are classified as discontinued operations.
- Current Business Status: NIMS is currently a shell company with no inventory or products available for sale. The company is exploring potential mergers and acquisitions as part of its future plans.
- Management Discussion and Analysis: The company has been primarily financed through private sales of equity securities and notes from related parties. Management is focused on improving the timeliness of SEC filings and has implemented measures to enhance internal reporting processes.
- Future Outlook: NIMS is assessing potential mergers and acquisitions to revitalize its business operations. The company acknowledges the need to raise additional capital to support these strategic initiatives.
Strategic Initiatives
- Strategic Initiatives: The company is currently a shell company and is actively seeking potential mergers, acquisitions, and strategic collaborations to enhance its business prospects. This strategic initiative is aimed at leveraging potential opportunities to revitalize the company's operations and financial standing.
- Capital Management: The company's capital management activities have primarily involved financing through private sales of equity securities and notes from related parties. As of July 31, 2025, the company had outstanding notes payable to related parties totaling $595,000, with interest accruing at 11% per annum. The company has not issued any new shares of common stock during the fiscal years 2025 and 2024. Additionally, the company has not declared any dividends on its common stock and does not anticipate doing so in the foreseeable future.
- Future Outlook: The company acknowledges substantial doubt about its ability to continue as a going concern due to its financial condition, including a net loss and negative working capital. It plans to raise additional capital to support its operations and strategic initiatives, although there is no assurance that such financing will be available on acceptable terms. The company is also focused on improving the timeliness of its SEC filings to maintain investor confidence and liquidity.
Challenges and Risks
- Financial Viability: There is substantial doubt about the company's ability to continue as a going concern due to recurring losses, an accumulated deficit of $29.0 million, and minimal cash reserves. Without additional equity or debt financing, the company may not be able to sustain operations.
- Funding Challenges: The company requires additional funding to continue operations, but there is no assurance that such funding will be available on acceptable terms. This could lead to significant dilution for shareholders or unfavorable terms in collaboration and licensing arrangements.
- Regulatory Compliance: The company has experienced delays in filing required reports with the SEC, which could negatively impact investor confidence and the liquidity of its securities.
- Internal Controls: Material weaknesses in internal controls over financial reporting have been identified, which could impair the company's ability to produce accurate financial statements.
- Corporate Governance: The lack of an independent audit or compensation committee may compromise the board's ability to manage the company effectively and independently.
- Stock Risks: The company's stock is classified as a "penny stock," which may make it difficult for investors to sell shares and could adversely affect the stock's market price.
SEC Filing: